SCHEMBL7992840

SCHEMBL7992840

COC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3ccc4ccccc4c3)CC2)C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
CYP3A4 P08684 2/20 1.00
CYP2D6 P10635 2/20 1.00
CYP2C9 P11712 1/20 1.00
OPRL1 P41146 8/20 0.71
OPRM1 P35372 6/20 0.57
OPRK1 P41145 5/20 0.57
BDKRB2 P30411 1/20 0.52
OPRD1 P41143 5/20 0.51
DRD2 P14416 1/20 0.51
DRD3 P35462 1/20 0.51
NPC1L1 Q9UHC9 2/20 0.49
MCHR1 Q99705 1/20 0.48
MMP1 P03956 1/20 0.46
MMP9 P14780 1/20 0.46
MMP13 P45452 1/20 0.46
ADAM17 P78536 1/20 0.46
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29789407 1.00 MEN1 (1.00) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7995842 0.89 CYP2D6 (0.80) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7995949 0.88 MEN1 (0.79) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7759170 0.87 MEN1 (0.77) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7982605 0.86 MEN1 (0.76) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7760221 0.85 MEN1 (0.75) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7994167 0.85 MEN1 (0.74) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7982648 0.85 OPRL1 (0.77) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7754132 0.84 MEN1 (0.72) MEN1KMT2ACYP3A4CYP2D6CYP2C9
SCHEMBL7760219 0.84 MEN1 (0.72) MEN1KMT2ACYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277991-B1 FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES NOVO NORDISK A/S (DK) 2001-08-21 US disclosed